Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells $409,310.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 30,500 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $13.42, for a total value of $409,310.00. Following the completion of the sale, the chief financial officer now owns 92,929 shares of the company’s stock, valued at approximately $1,247,107.18. This trade represents a 24.71 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total value of $435,811.88.
• On Tuesday, October 29th, Robert Thomas Freeman sold 4,483 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.01, for a total transaction of $53,840.83.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.50, for a total transaction of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total transaction of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.66, for a total value of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.00, for a total transaction of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total transaction of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total value of $16,500.00.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $11.49 on Friday. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.25. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of -14.92 and a beta of 1.45. The business’s fifty day moving average price is $11.59 and its 200-day moving average price is $9.35.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $662.11 million. During the same period last year, the firm posted ($0.19) earnings per share. The business’s revenue for the quarter was up 51.6% on a year-over-year basis. On average, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. KeyCorp started coverage on Alignment Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Piper Sandler reiterated an “overweight” rating and issued a $10.00 price target (up previously from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Robert W. Baird raised their price objective on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. Barclays lifted their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. Finally, Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $10.33.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Virtu Financial LLC purchased a new stake in shares of Alignment Healthcare in the 1st quarter worth $57,000. nVerses Capital LLC purchased a new stake in Alignment Healthcare in the third quarter worth about $95,000. Principal Financial Group Inc. raised its stake in shares of Alignment Healthcare by 18.1% in the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock worth $106,000 after buying an additional 2,077 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at about $131,000. Finally, Creative Planning grew its stake in shares of Alignment Healthcare by 20.0% during the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares during the period. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.